Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Chong Wei, Wei Zhang & Daobin Zhou. (2020) Central nervous system involvement at diagnosis in extranodal natural killer/T-cell lymphoma: a single-center study. Leukemia & Lymphoma 61:13, pages 3272-3274.
Read now
Read now
Shin Yeu Ong, Colin Phipps, Chandramouli Nagarajan, Tiffany Tang, Soon Thye Lim, Yeow Tee Goh & Yuh Shan Lee. (2020) Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia. Leukemia & Lymphoma 61:1, pages 225-227.
Read now
Read now
Jingjing Ma, Qing Li, Jie Shao, Yan Ma, Zhiguang Lin, Hui Kang & Bobin Chen. (2019) Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study. Cancer Management and Research 11, pages 10175-10185.
Read now
Read now
Nicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, Anthony D. Ho & Mathias Witzens-Harig. (2016) Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era. Leukemia & Lymphoma 57:11, pages 2619-2625.
Read now
Read now
Mark Roschewski & Kieron Dunleavy. (2015) Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors. Leukemia & Lymphoma 56:6, pages 1583-1584.
Read now
Read now
Articles from other publishers (37)
Christopher Hino, Curtis Lacy, Joel Brothers, Huynh Cao, Hamid Mirshahidi, Kiwon Park & Mojtaba Akhtari. (2023) Factors Influencing Physician Discretion to Administer CNS Prophylaxis in Diffuse Large B Cell Lymphoma: A Single Institution Retrospective Study. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Crossref
Mingxiao Lang, Youqin Feng, Xiangrui Meng, Jing Zhao, Zheng Song, Zhengzi Qian, Lihua Qiu, Shiyong Zhou, Xianming Liu, Lanfang Li, Haiyan Yang, Yuqin Song, Wei Li & Huilai Zhang. (2021) Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis. Hematological Oncology 41:2, pages 239-247.
Crossref
Crossref
Mami Hirasaki, Daisuke Takagi, Yoshiko Umeda, Motoki Moriwaki, Norimasa Katagiri, Akiko Nomoto, Tomohisa Ohno & Ichiro Fujishima. (2023) A Case of Dysphagia and Dysarthria Improved by Flexible-palatal Lift/augmentation Combination Prosthesis. Progress in Rehabilitation Medicine 8:0, pages n/a.
Crossref
Crossref
Joel Wight, Nada Hamad, Belinda A. Campbell, Matthew Ku, Kenneth Lee, Hannah Rose, Tasman Armytage, Maya Latimer, Hui‐Peng Lee, Sze‐Ting Lee, Michael Dickinson, Richard Khor & Emma Verner. (2022) Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 52:9, pages 1609-1623.
Crossref
Crossref
Kota Yokoyama, Jun Oyama, Junichi Tsuchiya, Jun Karakama, Kaoru Tamura, Motoki Inaji, Yoji Tanaka, Daisuke Kobayashi, Taketoshi Maehara & Ukihide Tateishi. (2022) Branch-like enhancement on contrast enhanced MRI is a specific finding of cerebellar lymphoma compared with other pathologies. Scientific Reports 12:1.
Crossref
Crossref
Desmond A. Brown, Anshit Goyal, Kent R. Richter, Jack M. Haglin, Benjamin T. Himes, Victor M. Lu, Kendall Snyder, Joshua Hughes, Paul A. DeckerMichael Opoku-Darko, Michael J. Link, Terry C. Burns & Ian F. Parney. (2022) Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma. Journal of Neurosurgery 136:1, pages 30-39.
Crossref
Crossref
Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez & Jose-Tomas Navarro. (2021) Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas. Cancers 13:21, pages 5534.
Crossref
Crossref
S. Zafar, R.K. Sharma, J. Cunningham, P. Mahalingam, A.D. Attygalle, N. Khan, D. Cunningham, D. El-Sharkawi, S. Iyengar & B. Sharma. (2021) Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift. Clinical Radiology 76:5, pages 391.e1-391.e18.
Crossref
Crossref
John Xie, Albert Jang, Motohide Uemura, Shigeaki Nakazawa, Teresa Calimeri, Andres JM Ferreri, Shuang R. Chen, Janet L. Schmid, Theresa C. Brown, Francisco Socola, Hana Safah & Nakhle S. Saba. (2021) Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review. Leukemia Research Reports 16, pages 100263.
Crossref
Crossref
Jun Ho Yi, Sang Eun Yoon, Kyung Ju Ryu, Young Hyeh Ko, Won Seog Kim & Seok Jin Kim. (2020) Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma. Cytokine 129, pages 155048.
Crossref
Crossref
Patrascu Ana Maria, Ionela Rotaru, Valeriu Surlin & Stefan Patrascu. 2020. Normal and Malignant B-Cell. Normal and Malignant B-Cell.
Melissa J. Garwood, Eliza A. Hawkes, Leonid Churilov & Geoffrey Chong. (2019) Patient selection and tolerability of high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology 85:1, pages 133-140.
Crossref
Crossref
Yuchen Wu, Yaming Wang, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Jiayuan Guo, Nan Ji, Shengjun Sun & Yuanbo Liu. (2019) Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurology 19:1.
Crossref
Crossref
Sinan DEMIRCIOGLU, Ufuk TELCI, Mahsun OZCELIK, Ali DOGAN & İrfan BAYRAM. (2019) Renal involvement in diffuse large B-cell lymphoma: A case report. Marmara Medical Journal 32:3, pages 144-146.
Crossref
Crossref
Xiaobei Liu, Fei Mo, Hao Zeng, Sha Zhu & Xuelei Ma. (2019) Quantitative proteomic analysis of cerebrospinal fluid from patients with diffuse large B‑cell lymphoma with central nervous system involvement: A novel approach to diagnosis. Biomedical Reports.
Crossref
Crossref
Hee Sang Hwang, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Yoon Se Lee, Young Hyeh Ko, Seok Jin Kim, Won Seog Kim, Cheolwon Suh & Jooryung Huh. (2018) The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms. Annals of Hematology 97:12, pages 2363-2372.
Crossref
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) Recomendaciones de GESIDA/PETHEMA sobre el diagnóstico y tratamiento de los linfomas en pacientes infectados por el virus de la inmunodeficiencia humana. Medicina Clínica 151:1, pages 39.e1-39.e17.
Crossref
Crossref
Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez & José-María Ribera Santasusana. (2018) GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. Medicina Clínica (English Edition) 151:1, pages 39.e1-39.e17.
Crossref
Crossref
Alexander Baraniskin, Monika Chomiak, Guido Ahle, Thomas Gress, Malte Buchholz, Michael Turewicz, Martin Eisenacher, Michelle Margold, Uwe Schlegel, Wolff Schmiegel, Stephan Hahn & Roland Schroers. (2018) MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS. Journal of Neuro-Oncology 137:3, pages 463-468.
Crossref
Crossref
Massimiliano Salati, Vittoria Tarantino, Antonino Maiorana, Stefania Bettelli & Stefano Luminari. (2017) Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy. Hematological Oncology 35:4, pages 861-863.
Crossref
Crossref
M. Gleeson, N. Counsell, D. Cunningham, N. Chadwick, A. Lawrie, E.A. Hawkes, A. McMillan, K.M. Ardeshna, A. Jack, P. Smith, P. Mouncey, C. Pocock, J.A. Radford, J. Davies, D. Turner, A. Kruger, P. Johnson, J. Gambell & D. Linch. (2017) Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial. Annals of Oncology 28:10, pages 2511-2516.
Crossref
Crossref
Joel Cunningham, Sunil Iyengar & Bhupinder Sharma. (2017) Evolution of lymphoma staging and response evaluation: current limitations and future directions. Nature Reviews Clinical Oncology 14:10, pages 631-645.
Crossref
Crossref
Hemant MurthyClaudio AnasettiErnesto Ayala. (2018) Diagnosis and Management of Leukemic and Lymphomatous Meningitis. Cancer Control 24:1, pages 33-41.
Crossref
Crossref
Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, Arnuparp Lekhakula, Suporn Chuncharunee, Pimjai Niparuck, Supachai Ekwattanakit, Archrob Khuhapinant, Lalita Norasetthada, Weerasak Nawarawong, Nisa Makruasi, Nonglak Kanitsap, Chittima Sirijerachai, Kanchana Chansung, Peerapon Wong, Tontanai Numbenjapon, Kannadit Prayongratana, Tawatchai Suwanban, Somchai Wongkhantee, Pannee Praditsuktavorn & Tanin Intragumtornchai. (2016) Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Annals of Hematology 96:1, pages 57-64.
Crossref
Crossref
Leslie Popplewell. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach
139
153
.
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin & Zhong-Jun Xia. (2016) New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Chinese Journal of Cancer 35:1.
Crossref
Crossref
Norbert Schmitz, Maike Nickelsen & Kerry J. Savage. (2016) Central Nervous System Prophylaxis for Aggressive B-cell Lymphoma. Hematology/Oncology Clinics of North America 30:6, pages 1277-1291.
Crossref
Crossref
Seok Jin Kim, Jun Sik Hong, Myung Hee Chang, Jeong-A Kim, Jae-Yong Kwak, Jin Seok Kim, Dok Hyun Yoon, Won Sik Lee, Young Rok Do, Hye Jin Kang, Hyeon-Seok Eom, Yong Park, Jong-Ho Won, Yeung-Chul Mun, Hyo Jung Kim, Jung Hye Kwon, Jee Hyun Kong, Sung Yong Oh, Sunah Lee, Sung Hwa Bae, Deok-Hwan Yang, Hyun Jung Jun, Yang Soo Kim, Hwan Jung Yun, Soon Il Lee, Min Kyoung Kim, Eun Kyung Park, Won Seog Kim & Cheolwon Suh. (2016) Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study. Oncotarget 7:44, pages 72033-72043.
Crossref
Crossref
Paolo F. Caimi, Brian T. Hill, Eric D. Hsi & Mitchell R. Smith. (2016) Clinical approach to diffuse large B cell lymphoma. Blood Reviews 30:6, pages 477-491.
Crossref
Crossref
Simone Canovi & Daniele Campioli. (2016) Accuracy of flow cytometry and cytomorphology for the diagnosis of meningeal involvement in lymphoid neoplasms: A systematic review. Diagnostic Cytopathology 44:10, pages 841-856.
Crossref
Crossref
Abhimanyu Ghose. (2016) CNS Prophylaxis in Diffuse Large B cell Lymphoma. Journal of Cancer Prevention & Current Research 5:5.
Crossref
Crossref
Norbert SchmitzSamira ZeynalovaMaike NickelsenRoopesh KansaraDiego VillaLaurie H. SehnBertram GlassDavid W. ScottRandy D. GascoyneJoseph M. ConnorsMarita ZiepertMichael PfreundschuhMarkus LoefflerKerry J. Savage. (2016) CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology 34:26, pages 3150-3156.
Crossref
Crossref
Futoshi Iioka, Kiyotaka Izumi, Yoshimasa Kamoda, Takashi Akasaka & Hitoshi Ohno. (2015) Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy. International Journal of Clinical Oncology 21:3, pages 498-505.
Crossref
Crossref
E. González-Barca, M. Canales, A. Salar, J. J. Ferreiro-Martínez, S. Ferrer-Bordes, J. A. García-Marco, J. J. Sánchez-Blanco, J. García-Frade, J. Peñalver, J. L. Bello-López, J. M. Sancho & D. Caballero. (2016) Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial. Annals of Hematology 95:6, pages 893-899.
Crossref
Crossref
Juan-Manuel Sancho & Josep-Maria Ribera. (2016) Recaída en el sistema nervioso central en el linfoma B difuso de célula grande: factores de riesgo. Medicina Clínica 146:2, pages 74-80.
Crossref
Crossref
Juan-Manuel Sancho & Josep-Maria Ribera. (2016) Central nervous system relapse in diffuse large B cell lymphoma: Risk factors. Medicina Clínica (English Edition) 146:2, pages 74-80.
Crossref
Crossref